U.S. markets closed

Canopy Growth Corporation (WEED.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
42.49-1.22 (-2.79%)
At close: 3:59PM EST
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close43.71
Bid42.47 x 0
Ask42.62 x 0
Day's Range41.90 - 44.60
52 Week Range12.96 - 44.60
Avg. Volume1,913,336
Market Cap15.88B
Beta (5Y Monthly)2.33
PE Ratio (TTM)N/A
EPS (TTM)-4.28
Earnings DateFeb 09, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est28.27
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • After Election Results, Sundial Is Still a Legalization Lottery Ticket

      After Election Results, Sundial Is Still a Legalization Lottery Ticket

      As you likely know, pot stocks are back in style. With the “blue wave” in Georgia, the Democratic Party now adds control of Congress atop its Presidential victory in November. This bodes well for Sundial Growers (NASDAQ:SNDL). Why? The election results greatly improve the chances that marijuana is legalized on the U.S. Federal level. That is the kind of game-changer hard-hit SNDL stock needs to get its motor running once again. Source: Shutterstock Yet, don’t take this to mean that Sundial’s fortunes have improved overnight. Still working on its turnaround, SNDL remains a very risky cannabis play. Sure, it’s gotten its debt problem under control. Plus, there’s more cash on hand to keep the lights on. But it is still an “also ran” name compared to larger players like Canopy Growth (NASDAQ:CGC). However, there’s still opportunity here. As a penny stock popular with retail investors, just a bit of positive news could jolt SNDL up to prices far above its current 70 cents per share. That said, this isn’t an opportunity for everybody.InvestorPlace - Stock Market News, Stock Advice & Trading Tips When it comes to Sundial, it won’t take much to drive an outsized rally and it won’t take much to send shares cratering, either. So, more cautious investors should steer clear. But, for folks looking for high-risk, high-potential return plays, this may be just the ticket. SNDL Stock and Legalization Progress Along with the executive branch, Democrats now have control of the U.S. legislature. What does that mean for pot legalization in the coming years? Admittedly, there’s still a long road ahead. 9 Stocks That Investors Think Are the Next Amazon However, Congress already has two marijuana reform bills in motion. These are the MORE Act and the STATES Act. The first, the Marijuana Opportunity Reinvestment and Expungement Act, fully removes marijuana’s status as a controlled substance. Secondly, the Strengthening the Tenth Amendment Through Entrusting States Act removes many of the conflicts arising between state and federal marijuana laws. But, these bills focus more on decriminalization. Further action may be needed to allow Canada-based pot companies like Sundial to enter the U.S. market. That said, any progress with these bills will be a step in the right direction. If either one gets signed into law, it could help drive another parabolic move higher for smaller pot plays like SNDL stock. And those trading this stock aren’t looking at its fundamentals. So, for the time being any move higher (or lower) largely hinges on how the legalization situation is playing out in Washington. Don’t Forget the Turnaround Story Legalization is what’s top of mind among those trading SNDL stock. But, don’t forget that the company’s turnaround story remains in play as well. If it can show solid improvement in its next quarterly earnings release, that may also be enough to fuel an outsized move. And that’s certainly possible. As I previously discussed, Sundial recently moved out of the lower-margin wholesale cannabis business and is now mainly a purveyor of branded cannabis products. Yet, it’s no slam dunk that this pivot will pay off. As InvestorPlace contributor Larry Sullivan wrote on Jan 7, only “time will tell” whether SNDL is on its way towards profitability. But even small potatoes improvement could be enough to move the needle. Why? As retail investors continue to dive in en masse based on headlines alone, we could see another big near-term move for SNDL stock. Just keep in mind that this makes it more of a near-term gamble than a sound investment. Finally, a great quarter is far from guaranteed. If we see atrocious numbers when Sundial next releases results, its shares could tank. But, with greater near-term potential for outsized gains rather than outsized losses, the risk-return may be in your favor. A Near-Term Trade That’s Not for Everybody There’s plenty in play to move this stock higher in the near-term. But there are some caveats to keep in mind. For instance, the company took care of its debt situation, but this came at the price of heavy dilution. When those newly issued shares start trading on the open market, we could see downward pressure on the stock. Also, outsized gains in the near-term are mainly possible due to Sundial’s penny stock status as a Nasdaq Exchange listing. This is what paves the way for the “Robinhood effect” to send it back into hyperdrive. However, given the company will soon have to reverse-split to maintain its market listing, time is running out for this outcome to play out. So, putting it simply, this pick remains a legalization lottery ticket, with potential improved quarterly results adding in some optionality. For some investors, the stock may be a worthwhile near-term trade. Otherwise, watch out. More of a gamble than an investment, SNDL stock remains a very risky opportunity. On the date of publication, Thomas Niel did not (either directly or indirectly) hold any positions in the securities mentioned in this article. Thomas Niel, a contributor to InvestorPlace, has written single stock analysis since 2016. On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks. Read More: Penny Stocks –How to Profit Without Getting Scammed More From InvestorPlace Why Everyone Is Investing in 5G All WRONG Top Stock Picker Reveals His Next 1,000% Winner It doesn’t matter if you have $500 in savings or $5 million. Do this now. The post After Election Results, Sundial Is Still a Legalization Lottery Ticket appeared first on InvestorPlace.

    • Marijuana Stocks Jump On Democratic Senate; Are Any Good Buys Now?
      Investor's Business Daily

      Marijuana Stocks Jump On Democratic Senate; Are Any Good Buys Now?

      Marijuana stocks surged as a Democratic Senate adds to cannabis legalization momentum. Are any pot stocks good buys now amid profitability challenges?

    • Aphria Stock, Marijuana Stocks Rally On Sales Beat, But Analyst Cites These Concerns
      Investor's Business Daily

      Aphria Stock, Marijuana Stocks Rally On Sales Beat, But Analyst Cites These Concerns

      Aphria stock and other marijuana stocks jumped on Thursday, after the Canadian cannabis producer reported fiscal second-quarter revenue that beat expectations. The pot grower reported the results after it agreed to merge with rival Tilray — potentially creating a global weed-industry giant — and as more focus shifts to the U.S. and its legalization prospects. Aphria reported net sales of 160.5 million Canadian dollars, or around $126.57 million.